Investing.com - Fresenius Medical Care (NYSE:FMS) ADR reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Fresenius Medical Care ADR announced earnings per share of $1.21 on revenue of $4.41B. Analysts polled by Investing.com anticipated EPS of $0.67 on revenue of $5.39B.
Fresenius Medical Care ADR shares are up 8.28% from the beginning of the year, still down 14.33% from its 52 week high of $46.55 set on July 29. They are outperforming the EUR/USD which is down 0% from the start of the year.
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
Fresenius Medical Care ADR's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar